4.6 Review

Results of the 4th scientific workshop of the ECCO (I): Pathophysiology of intestinal fibrosis in IBD

期刊

JOURNAL OF CROHNS & COLITIS
卷 8, 期 10, 页码 1147-1165

出版社

OXFORD UNIV PRESS
DOI: 10.1016/j.crohns.2014.03.008

关键词

Inflammatory bowel disease; Ulcerative colitis; Crohn's disease; Intestinal fibrosis; Microbiota; Genetics

资金

  1. Alfa Wassermann
  2. Sofar
  3. Abbot
  4. Ardeypharm
  5. Essex/MSD
  6. FALK
  7. Flamentera
  8. Novartis
  9. Roche
  10. Tillots
  11. UCB
  12. Zeller
  13. AbbVie

向作者/读者索取更多资源

The fourth scientific workshop of the European Crohn's and Colitis Organization (ECCO) focused on the relevance of intestinal fibrosis in the disease course of inflammatory bowel disease (IBD). The objective was to better understand the pathophysiological mechanisms of intestinal fibrosis, to identify useful markers and imaging modalities of fibrosis in order to assess its presence and progression, and, finally, to point out possible approaches for the prevention and the treatment of fibrosis. The results of this workshop are presented in three separate manuscripts. This first section describes the most important mechanisms that contribute to the initiation and progression of intestinal fibrosis in IBD including the cellular and molecular mediators, the extracellular matrix molecules and matrix metalloproteinases/tissue inhibitors of metalloproteinases-system, the microbiota products, the role of fat, genetic and epigenetic factors, as well as the currently available experimental models. Furthermore, it identifies unanswered questions in the field of intestinal fibrosis and provides a framework for future research. (C) 2014 European Crohn's and Colitis Organisation. Published by Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据